Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Page

Page

Back to topic

Efficacy and effectiveness of the COVID-19 vaccines

It is important that vaccines work well, and offer protection against disease. At the same time, vaccines also need to be safe for your health. This page describes how COVID-19 vaccines work.

Frequently Asked Questions

Newsletter on COVID-19 vaccination issue 4 2021

Risk factors for COVID-19: CONTEST study

Why do some people become ill from the coronavirus SARS-CoV-2 while others do not? Where do people contract the virus? This and other risk factors for COVID-19 are being investigated by RIVM in collaboration with the Netherlands Municipal Public Health Services and Medical Assistance in Accidents and Disasters (GGD-GHOR) in the CONTEST study.

Newsletter on COVID-19 vaccination issue 3 2021

Pathogen surveillance

SARS-CoV-2 pathogen surveillanceA virus changes constantly. The coronavirus SARS-CoV-2 is also constantly changing slightly. RIVM is conducting laboratory research to see how the virus is changing and what this means for the spread of the virus in the Netherlands. This is known as pathogen surveillance. 

COVID-19 vaccination - for professionals

Are you professionally involved in the COVID-19 vaccination? This site provides information for professionals involved in the implementation of COVID-19 vaccinations and other interested professionals. 

Figures on the COVID-19 vaccination programme

Q fever and COVID-19

At the start of the coronavirus epidemic in the Netherlands, there was a high incidence of COVID-19 in the eastern part of the province of Noord-Brabant. The affected area overlapped the region where cases of Q fever were common from 2007 to 2010. The geographical overlap was noted during the first wave of COVID-19. For that reason, RIVM investigated whether people who previously had Q fever had an increased risk of contracting COVID-19, and whether they had a more serious course of illness from COVID-19. 

Pagination

  • « « First
  • ‹ ‹ Previous
  • …
  • Page 88
  • Page 89
  • Page 90
  • Page 91
  • Current page 92
  • Page 93
  • Page 94
  • Page 95
  • Page 96
  • …
  • › Next ›
  • » Last »

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Social media house rules

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon